PD-Rx Pharmaceuticals, Inc. (PDRX)

USD 2.76

(0.0%)

Operating Expenses Summary of PD-Rx Pharmaceuticals, Inc.

  • PD-Rx Pharmaceuticals, Inc.'s latest annual operating expenses in 2022 was 6.9 Million USD , down -1.79% from previous year.
  • PD-Rx Pharmaceuticals, Inc.'s latest quarterly operating expenses in 2022 FY was 6.9 Million USD , down -1.79% from previous quarter.
  • PD-Rx Pharmaceuticals, Inc. reported a annual operating expenses of 7.02 Million USD in annual operating expenses 2021, up 15.57% from previous year.
  • PD-Rx Pharmaceuticals, Inc. reported a annual operating expenses of 6.08 Million USD in annual operating expenses 2020, down -6.4% from previous year.
  • PD-Rx Pharmaceuticals, Inc. reported a quarterly operating expenses of 7.02 Million USD for 2021 FY, up 15.57% from previous quarter.
  • PD-Rx Pharmaceuticals, Inc. reported a quarterly operating expenses of 6.08 Million USD for 2020 FY, down -6.4% from previous quarter.

Annual Operating Expenses Chart of PD-Rx Pharmaceuticals, Inc. (2022 - 2012)

Historical Annual Operating Expenses of PD-Rx Pharmaceuticals, Inc. (2022 - 2012)

Year Operating Expenses Operating Expenses Growth
2022 6.9 Million USD -1.79%
2021 7.02 Million USD 15.57%
2020 6.08 Million USD -6.4%
2019 6.49 Million USD -15.09%
2018 7.65 Million USD 0.08%
2017 7.64 Million USD 11.36%
2016 6.86 Million USD 0.88%
2015 6.8 Million USD 0.17%
2014 6.79 Million USD -4.19%
2013 7.09 Million USD 13.03%
2012 6.27 Million USD 0.0%

Peer Operating Expenses Comparison of PD-Rx Pharmaceuticals, Inc.

Name Operating Expenses Operating Expenses Difference
China Medicine Corporation 6.71 Million USD -2.73%
DH Enchantment Inc. 144.83 Thousand USD -4665.147%
Exlites Holdings International, Inc. 34.23 Thousand USD -20060.389%
Itonis, Inc. 40.11 Thousand USD -17104.732%
One Step Vending Corp. 26.55 Thousand USD -25892.415%
MediPal Holdings Corporation 1.22 Billion USD 99.437%
Pharmagen, Inc. 6038.12 USD -114198.921%
Suzuken Co., Ltd. 993.51 Million USD 99.305%